Impaired myocardial t-PA release in patients with coronary artery disease

Acta Anaesthesiologica Scandinavica

Volumn 52, Issue 10, 2008, Pages 1375-1384

  Osterlund B ^a,c   Jern, S ^b   Jern, C ^b   Seeman Lodding, H ^b   Ostman M ^a   Johansson, G ^a   Biber, B ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; ISOFLURANE; LACTIC ACID; MIDAZOLAM; PANCURONIUM; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ANESTHESIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; FEMALE; HEART ATRIUM PACING; HEART CATHETERIZATION; HEART RATE; HEART SURGERY; HUMAN; MALE; PRIORITY JOURNAL; RISK FACTOR; STERNOTOMY;

AGED; BLOOD PRESSURE; CARDIAC PACING, ARTIFICIAL; CARDIAC SURGICAL PROCEDURES; CATHETERIZATION, SWAN-GANZ; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

EID: 54049142446     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2008.01741.x     Document Type: Article

References (41)

1. Davies MJ. The pathophysiology of acute coronary syndromes. Heart 2000 83 (3) : 361 6.
2. van den Eijnden-Schrauwen Y, Kooistra T, de Vries RE, Emeis JJ. Studies on the acute release of tissue-type plasminogen activator from human endothelial cells in vitro and in rats in vivo: evidence for a dynamic storage pool. Blood 1995 85 (12) : 3510 7.
3. Emeis JJ. Regulation of the acute release of tissue-type plasminogen activator from the endothelium by coagulation activation products. Ann NY Acad Sci 1992 667 : 249 58.
4. Giles AR, Nesheim ME, Herring SW, Hoogendoorn H, Stump DC, Heldebrant CM. The fibrinolytic potential of the normal primate following the generation of thrombin in vivo. Thromb Haemost 1990 63 (3) : 476 81.
5. Rentrop KP, Feit F, Sherman W, Thornton JC. Serial angiographic assessment of coronary artery obstruction and collateral flow in acute myocardial infarction. Report from the second Mount Sinai-New York University reperfusion trial. Circulation 1989 80 (5) : 1166 75.
6. Ladenvall P, Wall U, Jern S, Jern C. Identification of eight novel single-nucleotide polymorphisms at human tissue-type plasminogen activator (t-PA) locus: association with vascular t-PA release in vivo. Thromb Haemost 2000 84 (2) : 150 5.
7. Tjarnlund-Wolf A, Olsson L, Medcalf RL, Jern C. Regulation of endogenous tissue-type plasminogen activator expression is modulated by the -7351C>T enhancer polymorphism. Thromb Haemost 2006 4 (6) : 1414 8.
8. Ladenvall P, Johansson L, Jansson JH, Jern S, Nilsson TK, Tjärnlund A, Jern C, Boman K. Tissue-type plasminogen activator -7,351C/T enhancer polymorphism is associated with a first myocardial infarction. Thromb Haemost 2002 87 (1) : 105 9.
9. Kathiresan S, Yang Q, Larsson MG, Camargo AL, Tofler GH, Hirschhorn JN, Gabriel SB, O'Donnell CJ. Common genetic variation in five thrombosis genes and relations to plasma hemostatic protein level and cardiovascular disease risk. Arterioscler Thromb Vasc Biol 2006 26 (6) : 1405 12.
10. Hrafnkelsdóttir T, Wall U, Jern C, Jern S. Impaired capacity for endogenous fibrinolysis in essential hypertension. Lancet 1998 352 (9140) : 1597 8.
11. Hrafnkelsdóttir T, Ottosson P, Gudnasson T, Samuelsson O, Jern S. Impaired endothelial release of tissue-type plasminogen activator in patients with chronic kidney disease and hypertension. Hypertension 2004 44 (11) : 300 4.
12. Van Guilder GP, Hoetzer GL, Greiner JJ, Stauffer BL, DeSouza CA. Metabolic syndrome and endothelial fibrinolytic capacity in obese adults. Am J Physiol Regul Integr Comp Physiol 2008 294 (1) : R39 44.
13. Takashima H, Matsumoto T, Nakae I, Yamane T, Horie M. Cigarette smoking impairs bradykinin-stimulated tissue plasminogen activator release in human coronary circulation. Thromb Res 2007 120 (6) : 791 6.
14. Newby DE, McLeod AL, Uren NG, Flint L, Ludlam CA, Webb DJ, Fox KA, Boon NA. Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: direct link between endothelial dysfunction and atherothrombosis. Circulation 2001 103 (15) : 1936 41.
15. Seeman-Lodding H, Häggmark S, Jern C, Jern S, Johansson G, Winsö O, Biber B. Aortic cross-clamping influences regional net release and uptake rates of tissue-type plasminogen activator in pigs. Acta Anaesthesiol Scand 1997 41 (9) : 1114 23.
16. Österlund B, Holmgren A, Häggmark S, Jern C, Johansson G, Seeman-Lodding H, Biber B. Surgical stress induces acute coronary release of tissue-type plasminogen activator in the pig. Acta Anaesthesiol Scand 2000 44 (10) : 1226 31.
17. Ganz W, Swan HJ. Measurement of blood flow by thermodilution. Am J Cardiol 1972 29 (2) : 241 6.
18. Bålfors E, Häggmark S, Ariola Jr. S, Biber B, Pontén J, Reiz S. In vitro analysis of thermal transport in coronary sinus thermodilution catheters. Clin Physiol 1983 3 (5) : 469 76.
19. Frank E. Accurate, clinically practical system for spatial vectorcardiography. Circulation 1956 13 : 737 44.
20. Jensen SM, Häggmark S, Johansson G, Näslund U. On-line computerized vectorcardiography: influence of body position, heart rate, radiographic contrast fluid and myocardial ischemia. Cardiology 1997 88 (6) : 576 84.
21. Ranby M, Nguyen G, Scarabin PY, Samama M. Immunoreactivity of tissue plasminogen activator and of its inhibitor complexes. Biochemical and multicenter validation of a two site immunosorbent assay. Thromb Haemost 1989 61 (3) : 409 14.
22. Meijer P, Pollet DE, Wauters J, Kluft C. Specificity of antigen assays of plasminogen activator inhibitor in plasma: innotest PAI-1 immunoassay evaluated. Clin Chem 1994 40 (1) : 110 5.
23. Gough SC, Smyllie J, Sheldon T, Rice PJ, Grant PJ. The anatomical distribution of plasma fibrinolytic activity in man during cardiac catheterisation. Thromb Haemost 1992 68 (4) : 442 7.
24. Mangano DT, Browner WS, Hollenberg M, London MJ, Tubau JF, Tateo IM. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N Engl J Med 1990 323 (26) : 1781 8.
25. Robinson SD, Ludlam CA, Boon NA, Newby DE. Endothelial fibrinolytic capacity predicts future adverse cardiovascular events in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 2007 27 (7) : 1651 6.
26. Seeman-Lodding H, Häggmark S, Jern C, Jern S, Johansson, Winsö O, Biber B. Systemic levels and preportal organ release of tissue-type plasminogen activator are enhanced by PEEP int the pig. Acta Anaesthesiol Scand 1999 43 (6) : 623 33.
27. Österlund B, Jern C, Seeman-Lodding H, Johansson G, Häggmark S, Broomé M, Biber B. Intracoronary beta2 receptor activation induces dynamic local t-PA release in the pig. Thromb Haemost 2003 90 (5) : 796 802.
28. Gossinger HD, Speiser W, Siostrzonek P, Jung M, Kyrle PA, Heistinger M, Lechner K, Mösslacher H. Pacing-induced myocardial ischemia does not affect the endothelial release of coagulant and fibrinolytic factors into the coronary circulation. Clin Cardiol 1991 14 (3) : 250 6.
29. Björkman JA, Jern S, Jern C. Cardiac sympathetic nerve stimulation triggers coronary t-PA release. Arterioscler Thromb Vasc Biol 2003 23 (6) : 1091 7.
30. Minai K, Matsumoto T, Horie H, Ohira N, Takashima H, Yokohama H, Kinoshita M. Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: effects of angiotensin-converting enzyme inhibitors. J Am Coll Cardiol 2001 37 (6) : 1565 70.
31. Jern C, Selin L, Jern S. In vivo release of tissue-type plasminogen activator across the human forearm during mental stress. Thromb Haemost 1994 72 (2) : 285 91.
32. Stein CM, Brown N, Vaughan DE, Lang CC, Wood AJ. Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature. J Am Coll Cardiol 1998 32 (1) : 117 22.
33. Kirnö K, Friberg P, Grzegorczyk A, Milocco I, Ricksten SE, Lundin S. Thoracic epidural anesthesia during coronary artery bypass surgery: effects on cardiac sympathetic activity, myocardial blood flow and metabolism, and central hemodynamics. Anesth Analg 1994 79 (6) : 1075 81.
34. von Kanel R, Dimsdale JE. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol 2000 65 (6) : 357 69.
35. Hrafnkelsdottir T, Gudnason T, Wall U, Jern C, Jern S. Regulation of local availability of active tissue-type plasminogen activator in vivo in man. Thromb Haemost 2004 2 : 1960 8.
36. Wolfram G, Meyer U, Scheske U, Horn M, Drummer C, Spannagl M, Gerzer R. Effect of organic nitrates on ex vivo platelet aggregation and fibrinolysis in man. Eur J Med Res 1996 1 (6) : 291 8.
37. Newby DE, Witherow FN, Wright RA, Bloomfield P, Ludlam CA, Boon NA, Fox KA, Webb DJ. Hypercholesterolaemia and lipid lowering treatment do not affect the acute endogenous fibrinolytic capacity in vivo. Heart 2002 87 (1) : 48 53.
38. Dumoulin MJ, Adam A, Rouleau JL, Lamontagne D. Comparison of a vasopeptidase inhibitor with neutral endopeptidase and angiotensin-converting enzyme inhibitors on bradykinin metabolism in the rat coronary bed. J Cardiovasc Pharmacol 2001 37 (4) : 359 66.
39. Newby DE, Wright RA, Labinjoh C, Ludlam CA, Fox KA, Boon NA, Webb DJ. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. Circulation 1999 99 (11) : 1411 5.
40. Haverkate F, Thompson SG, Duckert F. Haemostasis factors in angina pectoris; relation to gender, age and acute-phase reaction. Results of the ECAT Angina Pectoris Study Group. Thromb Haemost 1995 73 (4) : 561 7.
41. Gudnason T, Hrafnkelsdottir T, Wall U, Swedberg K, Jern S. Fibrinolytic capacity increases with age in healthy humans, while endothelium-dependent vasodilation is unaffected. Thromb Haemost 2003 89 (2) : 374 81.